General financial question that shows my lack of knowledge but what ultimately determines how long a company can continue to raise capital to stay afloat?
There is a table in the financial report that shows what proportion of debt is due in coming years. Some debt repayments have been deferred till product approval and so on but also thinking about our operating costs and anticipated delays to fda product approval as big factors. Without some partnerships and upfront payments or a big increase from royalties, how much time do we have before likely of being deemed unviable? Appreciate some insight thanks.
MSB Trading 2021 - paradigm shift, page-6
-
- There are more pages in this discussion • 10,205 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.05 |
Change
0.080(8.25%) |
Mkt cap ! $1.198B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.06 | 99.0¢ | $4.930M | 4.779M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 23545 | $1.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.05 | 339479 | 5 |
View Market Depth
| Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |